Gerd Zettlmeissl joined Intercell in 2001 as COO and has served as CEO since 2005.
His scientific background is in Molecular Biology and Protein Biochemistry. He holds a doctorate from the University of Regensburg and joined Behringwerke AG Marburg, Germany in 1985 after conducting five years of academic research at the University of Regensburg and at the Institut Pasteur in Paris. Between 1994 and 1996, Gerd Zettlmeissl was highly involved in the business' merger with Chiron. From the beginning of 2000 onwards, in addition to his global responsibilities, he was CEO of Chiron's German subsidiary, Chiron-Behring. Furthermore, he is the author of numerous scientific publications and inventor/co-inventor of numerous patents in the field of biotechnology.
Gerd Zettlmeissl is a member of the Supervisory Board of the "Helmholtz Zentrum fuer Infektionsforschung GmbH", a public research institute in Braunschweig, Germany.